Kymera Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $525k | 13k | 40.20 |
| 2023-12-31 | $275k | 11k | 25.46 |
| 2023-09-30 | $504k | 36k | 13.90 |
| 2023-06-30 | $1.2M | 53k | 22.99 |
| 2022-12-31 | $51k | 2.0k | 24.96 |
| 2022-09-30 | $77k | 3.5k | 21.98 |
| 2022-06-30 | $177k | 9.2k | 19.35 |
| 2022-03-31 | $782k | 19k | 42.34 |
| 2021-12-31 | $1.9M | 29k | 63.49 |
| 2021-09-30 | $0 | 36k | 0.00 |
| 2021-06-30 | $69k | 1.4k | 48.49 |
| 2021-03-31 | $34k | 889 | 38.55 |
| 2020-12-31 | $668k | 11k | 61.92 |